CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Clinical trial NCT05043571 · RECRUITING

Trial details

NCT number: NCT05043571
Sponsor: National University Hospital, Singapore
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute, Childhood Lymphoblastic Leukemia Lymphoblastic Leukemia, Acute Adult Lymphoblastic Leukemia in Children CAR CAR T-Cell-Related Encephalopathy Syndrome Refractory Leukemia

Start date: 2021-09-08
Primary completion: 2026-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.